Gujarat-based pharmaceutical packaging company Medicap Healthcare has reduced the size of its initial public offering (IPO) by 29% and decided to drop the pre-IPO placement component from the revised offer structure, according to an addendum published on November 21.
In its notice to investors, the company said that, pursuant to a board resolution dated November 15, it had decided to reduce the issue size from Rs 240 crore, as disclosed in the draft red herring prospectus (DRHP), to Rs 170 crore. It also decided not to issue specified securities through a pre-IPO placement as part of the offering.
The revision is in line with SEBI regulations and related guidelines, which allow issuers to increase or decrease the fresh issue size by up to 50% without refiling the DRHP for IPOs opening on or before March 31, 2027.
Medicap Healthcare filed its draft offer document with the capital markets regulator in September 2025. Subsequently, SEBI approved the IPO papers in January 2026.
The proposed IPO initially comprised an entirely fresh issue, with no offer-for-sale (OFS) component. The fresh issue structure also included a proposed pre-IPO placement of Rs 48 crore.